Clinical CompetenceInternship and ResidencyLeadership
Dr. Sirisha Karri, MD
NPI1821217159PAC ID0648332395
- Medicare services, 2022
- 23
- Medicare patients, 2024
- 22
- Part D claims, 2024
- 839
- Publications
- 8
- Clinical trials
- 1
- Practice address
- 7373 West Ln, Stockton, CA 95210
- Practice phone
- Call (209) 476-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Permanente Medical Group Inc
Stockton, California
Find Dr. Karri's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sirisha Karri is a hematologist and oncologist in Stockton, California
Dr. Karri practices at Permanente Medical Group Inc in Stockton, California.
Dr. Karri's NPI, 1821217159, was assigned on April 25, 2007. Dr. Karri graduated from Osmania Medical College NTR UHS in 1998. Dr. Karri's Texas license number on file is N0877.
NPI and contact details
- NPI
- 1821217159NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0648332395
- NPI enumeration date
- April 25, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (209) 476-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sirisha Karri practices at Permanente Medical Group Inc in Stockton, California
Dr. Karri's primary practice is Permanente Medical Group Inc, at 7373 West Ln, Stockton, CA 95210 in San Joaquin County. The practice phone is (209) 476-2000.
- Permanente Medical Group Inc7373 West Ln, Stockton, CA 95210 · San Joaquin CountyPhone(209) 476-2000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Sirisha Karri is affiliated with 2 sites of care and 1 medical group
Dr. Karri's primary practice is Permanente Medical Group Inc in Stockton, California. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Karri to 1 more group practice or clinic, named with a free account.
Permanente Medical Group IncPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Sirisha Karri's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karri practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Permanente Medical Group Inc | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Karri practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sirisha Karri is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Karri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Karri is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Karri's licenses on file in 2 states: Texas and California.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- California license
Clinical focus
Dmand AI lists multiple myeloma among the conditions Dr. Karri treats.
Hematologists and oncologists near Dr. Karri
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sirisha Karri billed Medicare for 23 services in 2022
CMS data shows 23 Medicare services from Dr. Karri across 1 procedure code in 2022, for 22 Medicare patients. Medicare paid $2,488 for them. Every service was in an office.
Medicare services, 202223
Medicare patients22
Paid by Medicare$2,488
Procedure codes1
Dr. Karri's Medicare services by type, 2017 to 2022
- 2017
- 2022
- Tests and treatments
- 2017: 02022: 23
- Other services
- 2017: 1872022: 0100%
- Office and hospital visits
- 2017: 1572022: 0100%
Dr. Karri compared with the California median for hematologists and oncologists, 2022
- Dr. Karri
- California median
- Medicare services
- 23vs 93298% below
- Medicare patients
- 22vs 22590% below
- Part D claims
- 657vs 39467% above
Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.
Dr. Karri's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Karri?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Karri and other hematologists and oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sirisha Karri treated 22 Medicare patients in 2024, average age 66
CMS counts 22 Medicare patients who saw Dr. Karri in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Karri's median patient age at 64, with 59% women.
Medicare patients, 202422
Average age66
Average risk score1.90
Dr. Karri's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Karri's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 64
Patient panel by sex, all payers
- Women59%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Sirisha Karri wrote 839 Medicare Part D claims in 2024
In 2024, Dr. Karri wrote 839 Medicare Part D claims for 195 patients. 87% of them were for generic drugs. CMS names the drug for 657 of them, across 20 drugs with 11 or more claims each, at $170,588 in total drug cost. In 2023, CMS named 612 claims across 21 drugs.
Part D claims, 2024839
Drugs named by CMS20
Total drug cost$170,588
Part D patients195
Dr. Karri's Part D claims by kind of drug, 2024
- Generic732 claims87%
- Brand-name107 claims13%
Dr. Karri's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Karri's Part D claims, 2024
- Opioids18%153 of 839 claims
- Antibiotics2%18 of 839 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6122024: 6577%
Drugs named by CMS: 20 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Sirisha Karri offers telehealth to Medicare patients
Dr. Karri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karri as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Karri by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sirisha Karri has 8 publications on record
Dmand AI links 8 papers to Dr. Karri, published from 2006 to 2020. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Capecitabine and Chemoradiotherapy. Dr. Karri has published most often in Am J Clin Oncol. Dr. Karri's most frequent co-authors are Abier Abdelhamid Abdelnaby, MD, Yull Edwin Arriaga, MD and Jeffrey John Meyer, MD.
Papers8
Years published2006 to 2020
Dr. Karri's papers by year, 2006 to 2020
Topics Dr. Karri writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Capecitabine
- Chemoradiotherapy
- Fluorouracil
Dr. Karri's most frequent co-authors
- Abier Abdelhamid Abdelnaby, MD2 shared papers
- Yull Edwin Arriaga, MD2 shared papers
- Jeffrey John Meyer, MD2 shared papers
Recent publications by Dr. Karri
Semin Musculoskelet Radiol
Diagnosis, DifferentialDiffusion Magnetic Resonance ImagingImage Enhancement
Invest New Drugs
Administration, OralAntineoplastic Combined Chemotherapy ProtocolsArea Under Curve
Antineoplastic AgentsLomustineLymphoma, Non-Hodgkin
AdenocarcinomaAntibodies, MonoclonalAntineoplastic Combined Chemotherapy Protocols
See who Dr. Karri researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Karri works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sirisha Karri has worked on 1 clinical trial
Dmand AI links Dr. Karri to 1 clinical trial. Conditions studied include Carcinoma, Pancreatic Ductal and Carcinoma, Ductal.
Conditions in Dr. Karri's trials
- Carcinoma, Pancreatic Ductal
- Carcinoma, Ductal
Investigators on the most trials with Dr. Karri
Recent clinical trials with Dr. Karri
QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer (opens in a new tab)
CompletedPhase 1/2
Carcinoma, Pancreatic DuctalCarcinoma, DuctalNPC-1C/NEO-102
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Sirisha Karri has 1 award and honors on record
Dmand AI lists 1 award for Dr. Karri, most recently CMS Stage 1 EHR in 2011.
Awards and honors for Dr. Karri
- 2011
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Sirisha Karri graduated from Osmania Medical College NTR UHS
Dr. Karri graduated from Osmania Medical College NTR UHS in 1998. Dr. Karri is a member of ASCO.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Sirisha Karri accepts plans from 2 insurance carriers
Dr. Karri is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Karri accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Sirisha Karri's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sirisha Karri
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sirisha Karri's NPI number?
Dr. Sirisha Karri's NPI number is 1821217159. It was assigned on April 25, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Sirisha Karri?
Dr. Sirisha Karri is a hematologist and oncologist in Stockton, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Sirisha Karri practice?
Dr. Karri practices at 7373 West Ln, Stockton, CA 95210. Dr. Karri's primary practice is Permanente Medical Group Inc in Stockton, California. Dmand AI also links Dr. Karri to 1 group practice or clinic.
What is Dr. Sirisha Karri's office phone number?
The practice phone on file for Dr. Karri is (209) 476-2000.
What is Dr. Sirisha Karri's medical license number?
Dr. Karri's Texas license number on file is N0877, one of the licenses on file in 2 states.
Which states has Dr. Sirisha Karri been licensed in?
Dmand AI has state licenses on file for Dr. Karri in Texas (2008 to 2025) and California (2017 to 2025).
What medical group is Dr. Sirisha Karri part of?
Dr. Karri is linked to The Permanente Medical Group, Inc.
Does Dr. Sirisha Karri accept Medicare?
Yes. CMS data shows Dr. Karri billed Medicare for 23 services in 2022, and Dr. Karri accepts Medicare assignment.
Does Dr. Sirisha Karri offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Karri as offering telehealth services.
How many Medicare patients does Dr. Sirisha Karri see?
CMS counts 22 Medicare patients who saw Dr. Karri in 2024, with an average age of 66.
Show 8 more questionsShow fewer questions
Is Dr. Sirisha Karri board certified?
Yes. Dr. Karri is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Sirisha Karri bill to Medicare?
In 2022, Dr. Karri's most billed Medicare services were infusion or chemotherapy administration (96413).
Where did Dr. Sirisha Karri go to medical school?
Dr. Karri graduated from Osmania Medical College NTR UHS in 1998.
What drugs does Dr. Sirisha Karri prescribe most?
In 2024 Medicare Part D data, Dr. Karri's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron HCl and Gabapentin.
How long has Dr. Sirisha Karri been practicing?
Dr. Karri graduated from medical school in 1998, 28 years ago.
Does Dr. Sirisha Karri do research?
Dmand AI links 8 publications to Dr. Karri, published from 2006 to 2020. Dr. Karri has worked on 1 clinical trial.
Who does Dr. Sirisha Karri publish with?
Dr. Karri's most frequent co-authors are Abier Abdelhamid Abdelnaby, MD (2 shared papers), Yull Edwin Arriaga, MD (2 shared papers) and Jeffrey John Meyer, MD (2 shared papers).
What insurance does Dr. Sirisha Karri accept?
Dr. Karri is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card